In re Suboxone Antitrust Litigation

The 3rd Circuit affirmed granting class certification to a group of who purchased Suboxone from its manufacturer in In re Suboxone Antitrust Litigation. The class alleged that the manufacturer engaged in unfair trade practice to drive prescribers away from Suboxone tablets and toward under-the-tongue films in order to drive market share away from generic tablet manufacturers.  

Suboxone